Antiviral Therapy [topp]    
Combination [qlco]    
Low dose [qnco]    
Prevention [topp]    
HEPATITIS B VIRUS [virs]    
Liver transplant recipient [fndg]    
Single [popg]    
Centre [spco]    
experience [menp]    
objectives [inpr]    
Study [mnob]    
Present [qnco]    
Long Term [tmco]    
HEPATITIS B VIRUS [virs]    
GIVEN [cnce]    
Combination [qlco]    
Antiviral [phsu]    
Drugs [phsu]    
Patients [podg]    
Methods [inpr]    
September [tmco]    
2000s [tmco]    
October [qlco]    
Medical Records [inpr]    
ADULT [aggp]    
Patients [podg]    
Liver Transplantation [topp]    
Medical [hlca]    
Chronic Liver Failure [dsyn]    
HEPATOCELLULAR CARCINOMA [neop]    
secondary [neop]    
Hepatitis B, Chronic [dsyn]    
reviewed [inpr]    
Risk Factors [qnco]    
Performed [ftcn]    
Based [ftcn]    
Efficacy [qlco]    
Hepatitis B antigen [imft]    
envelope [celc]    
HBe Ag [imft]    
Preoperative [tmco]    
prophylaxis [inpr]    
HEPATOCELLULAR CARCINOMA [neop]    
HEPATITIS B VIRUS [virs]    
Defined [inpr]    
Persistence [menp]    
Orthotopic Liver Transplantation [topp]    
Initial [tmco]    
Undetectable [clna]    
prophylaxis [inpr]    
Patients [podg]    
prophylaxis [inpr]    
3 5 [qnco]    
Patients [podg]    
prophylaxis [inpr]    
>90 [qnco]    
Patients [podg]    
RECEIVED [qlco]    
prophylaxis [inpr]    
Groups [idcn]    
Groups [idcn]    
univariate analysis [resa]    
Preoperative [tmco]    
Preoperative [tmco]    
prophylaxis [inpr]    
HEPATOCELLULAR CARCINOMA [neop]    
Correlation [qlco]    
HBe Ag [imft]    
Statistical Significance [qnco]    
Conclusions [idcn]    
Low dose [qnco]    
Combination [qlco]    
ANTIVIRAL AGENTS [phsu]    
Efficacy [qlco]    
PREVENT [phsu]    
HEPATITIS B VIRUS [virs]    
Patients [podg]    
